These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34589111)

  • 41. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aptamers in the Treatment of Bacterial Infections: Problems and Prospects].
    Zeninskaya NA; Kolesnikov AV; Ryabko AK; Shemyakin IG; Dyatlov IA; Kozyr AV
    Vestn Ross Akad Med Nauk; 2016; 71(5):350-8. PubMed ID: 29297663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aptamers: potential applications to pancreatic cancer therapy.
    Rialon KL; White RR
    Anticancer Agents Med Chem; 2011 Jun; 11(5):434-41. PubMed ID: 21492073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.
    Prakash JS; Rajamanickam K
    Biomedicines; 2015 Sep; 3(3):248-269. PubMed ID: 28536411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].
    Zhang YB; Wang YP; Liu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):421-427. PubMed ID: 29764582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleic acid aptamers in human viral disease.
    Zhang Z; Blank M; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):307-15. PubMed ID: 15507871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells.
    Liu B; Liu J; Hu X; Xiang W; Hou W; Li C; Wang J; Yao K; Tang J; Long Z; Wang L; Liu J
    Mater Today Bio; 2023 Apr; 19():100605. PubMed ID: 36969696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer.
    Zhu G; Zhang H; Jacobson O; Wang Z; Chen H; Yang X; Niu G; Chen X
    Bioconjug Chem; 2017 Apr; 28(4):1068-1075. PubMed ID: 28122449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleic acid-based aptamers: applications, development and clinical trials.
    Kanwar JR; Roy K; Maremanda NG; Subramanian K; Veedu RN; Bawa R; Kanwar RK
    Curr Med Chem; 2015; 22(21):2539-57. PubMed ID: 25723512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
    Panigaj M; Johnson MB; Ke W; McMillan J; Goncharova EA; Chandler M; Afonin KA
    ACS Nano; 2019 Nov; 13(11):12301-12321. PubMed ID: 31664817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the stability of aptamers by chemical modification.
    Wang RE; Wu H; Niu Y; Cai J
    Curr Med Chem; 2011; 18(27):4126-38. PubMed ID: 21838692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aptamers as imaging agents.
    Gomes Sda R; Azéma L; Allard M; Toulmé JJ
    Expert Opin Med Diagn; 2010 Nov; 4(6):511-8. PubMed ID: 23496229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Advances in the study of aptamer-based drug for targeting therapy].
    Dou XQ; Fu J; Song HF
    Yao Xue Xue Bao; 2016 Jul; 51(7):1068-76. PubMed ID: 29897179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers.
    Mercier MC; Dontenwill M; Choulier L
    Cancers (Basel); 2017 Jun; 9(6):. PubMed ID: 28635657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analytical applications of aptamers.
    Tombelli S; Minunni M; Mascini M
    Biosens Bioelectron; 2005 Jun; 20(12):2424-34. PubMed ID: 15854817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases.
    Xu Y; Jiang X; Zhou Y; Ma M; Wang M; Ying B
    Front Bioeng Biotechnol; 2021; 9():704077. PubMed ID: 34447741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.